Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.

El-Mallawany NK, Kamiyango W, Slone JS, Villiera J, Kovarik CL, Cox CM, Dittmer DP, Ahmed S, Schutze GE, Scheurer ME, Kazembe PN, Mehta PS.

PLoS One. 2016 Apr 15;11(4):e0153335. doi: 10.1371/journal.pone.0153335. eCollection 2016.

2.

Classical Kaposi's Sarcoma in a Nigerian Farmer: A Case Report.

Iroezindu MO, Achusi IB.

Eurasian J Med. 2015 Jun;47(2):158-60. doi: 10.5152/eurasianjmed.2015.102.

3.

Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.

Minhas V, Wood C.

Viruses. 2014 Nov 4;6(11):4178-94. doi: 10.3390/v6114178. Review.

4.

Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).

Koski L, Ngoma T, Mwaiselage J, Le L, Soliman AS.

Int J STD AIDS. 2015 Jun;26(7):470-8. doi: 10.1177/0956462414544724. Epub 2014 Jul 30.

5.

Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Stolka K, Ndom P, Hemingway-Foday J, Iriondo-Perez J, Miley W, Labo N, Stella J, Abassora M, Woelk G, Ryder R, Whitby D, Smith JS.

Cancer Epidemiol. 2014 Apr;38(2):137-43. doi: 10.1016/j.canep.2014.02.006. Epub 2014 Mar 13.

6.

Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study.

Akarolo-Anthony SN, Maso LD, Igbinoba F, Mbulaiteye SM, Adebamowo CA.

Infect Agent Cancer. 2014 Mar 5;9(1):1. doi: 10.1186/1750-9378-9-1.

7.

A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

Dow DE, Cunningham CK, Buchanan AM.

J Pediatric Infect Dis Soc. 2014 Mar;3(1):66-76. doi: 10.1093/jpids/pit051. Epub 2013 Sep 4. Review.

8.

HHV-8 seroprevalence: a global view.

Rohner E, Wyss N, Trelle S, Mbulaiteye SM, Egger M, Novak U, Zwahlen M, Bohlius J.

Syst Rev. 2014 Feb 12;3:11. doi: 10.1186/2046-4053-3-11. Review.

9.

A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis.

Chang JT, Shebl FM, Pfeiffer RM, Biryahwaho B, Graubard BI, Mbulaiteye SM.

Infect Agent Cancer. 2013 Jan 16;8(1):3. doi: 10.1186/1750-9378-8-3.

10.

HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.

Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ.

Infect Agent Cancer. 2011 Oct 17;6(1):16. doi: 10.1186/1750-9378-6-16.

11.

Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.

Zheng D, Wan J, Cho YG, Wang L, Chiou CJ, Pai S, Woodard C, Zhu J, Liao G, Martinez-Maza O, Qian J, Zhu H, Hayward GS, Ambinder RF, Hayward SD.

J Infect Dis. 2011 Dec 1;204(11):1683-91. doi: 10.1093/infdis/jir645. Epub 2011 Oct 11.

12.

Human herpesvirus 8 seropositivity among sexually active adults in Uganda.

Shebl FM, Dollard SC, Pfeiffer RM, Biryahwaho B, Amin MM, Munuo SS, Hladik W, Parsons R, Graubard BI, Mbulaiteye SM.

PLoS One. 2011;6(6):e21286. doi: 10.1371/journal.pone.0021286. Epub 2011 Jun 21.

13.

Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.

Mbulaiteye SM, Goedert JJ.

J Infect Dis. 2011 Mar 1;203(5):575-7. doi: 10.1093/infdis/jiq094. Epub 2011 Jan 26. No abstract available.

Supplemental Content

Support Center